Carcinogen in Zantac and generic heartburn drugs triggers investigations

Los Angeles TimesDrug-safety officials in the United States and Europe said Friday that they were looking into whether Sanofi heartburn medication Zantac and generic versions made by numerous manufacturers contain levels of the probable carcinogen NDMA that could pose ...

September 14th 2019


Zantac Heartburn Drug May Contain Carcinogen: FDA

WebMDFRIDAY, Sept. 13, 2019 (HealthDay News) -- A substance that could cause cancer has been found in some ranitidine heartburn and ulcer medicines, including the brand-name drug Zantac, and the source of this contamination is being investigated, the U.S. ...

September 14th 2019


Zantac has low levels of cancer-causing chemical, FDA warns

CBS NewsThe federal agency said the carcinogenic ingredient is a type of nitrosamine called N-nitrosodimethylamine, or NDMA. The agency said patients can continue taking Zantac and similar heartburn medications for now, but patients using prescription versions ...

September 14th 2019


FDA finds probable carcinogen in Zantac and other heartburn drugs

USA TODAYA probable carcinogen that prompted the recall of several versions of blood pressure-lowering pills has been detected in the heartburn drug Zantac and its generic versions, the Food and Drug Administration said Friday. The FDA and European drug ...

September 14th 2019